2024-10-15 - Analysis Report
## HCA Healthcare Inc. (HCA) Stock Analysis Report

**Company Overview:** HCA Healthcare Inc. is one of the largest healthcare providers in the United States, offering a wide range of services, including hospitals, surgery centers, and physician practices.

**Performance Analysis:**

**1. Performance Comparison:**

* **Cumulative Return (HCA):** 321.93%
* **Cumulative Return (S&P 500, VOO):** 135.82%
* **Relative Performance (HCA vs. VOO):** 186.11% (92.48% percentile compared to historical performance).

HCA has significantly outperformed the S&P 500 over the period analyzed, with a cumulative return nearly 2.5 times greater than the benchmark index. Its relative performance places it at the 92.48% percentile compared to its historical performance, suggesting strong performance relative to its own historical trend.

**2. Recent Price Movement:**

* **Closing Price:** $394.54
* **5-Day Moving Average:** $385.6
* **20-Day Moving Average:** $397.96
* **60-Day Moving Average:** $380.05

The stock is currently trading slightly below its 20-day moving average, indicating a potential short-term pullback. However, the price is still above its 60-day moving average, suggesting overall upward momentum. 

**3. Technical Indicators:**

* **RSI:** 40.08
* **PPO:** -0.66
* **Delta_Previous_Relative_Divergence:** -3.83 (Short-term downward trend)
* **Expected Return:** 7.69% (Potential 5-year expected return exceeding S&P 500 by this percentage)

The RSI suggests the stock is currently in a slightly oversold territory, while the PPO indicates bearish momentum. The negative Delta_Previous_Relative_Divergence suggests a recent decline in relative performance. However, the expected return remains positive, suggesting potential for future growth.

**4. Recent Earnings and Outlook:**

| Date | EPS | Revenue |
|---|---|---|
| 2024-07-29 | 5.6 | $17.49B | 
| 2024-05-02 | 6.01 | $17.34B | 
| 2023-10-26 | 3.98 | $16.21B | 
| 2023-08-02 | 4.35 | $15.86B |
| 2024-07-29 | 4.35 | $15.86B |

HCA has consistently reported strong revenue growth and earnings per share (EPS), exceeding analysts' expectations in recent quarters. This positive performance indicates solid underlying business fundamentals and strong demand for healthcare services. The company's outlook for the future is positive, with analysts expecting continued growth in revenue and earnings.

**5. News and Recent Issues:**

* **Recent Market Outlook:** HCA remains a strong player in the healthcare sector, with its focus on providing quality care and leveraging technology for improved efficiency. The company's strong financial performance and its expansion in key markets have attracted positive attention from investors.
* **Analyst Opinions:** Most analysts remain bullish on HCA's stock, citing its strong financial performance, stable cash flows, and potential for continued growth in the healthcare sector.
* **Performance Highlights:**  HCA's strong earnings performance and robust revenue growth continue to drive investor interest. The company's focus on expanding its geographic footprint and its investments in innovative technologies are expected to contribute to further growth in the future.

**6. Comprehensive Analysis:**

HCA Healthcare Inc. demonstrates a strong performance history with impressive outperformance against the S&P 500. While the stock is experiencing a minor pullback in the short term, overall momentum remains positive. Recent earnings results indicate strong financial performance and a solid outlook for future growth. Positive analyst sentiments and the company's focus on innovation and expansion reinforce the potential for further growth in the future.

**7. Conclusion:**

HCA Healthcare Inc. remains a solid investment option for investors seeking exposure to the healthcare sector. The company's strong financial performance, positive outlook, and growth strategy make it a compelling investment opportunity. However, potential investors should consider the stock's current price and its recent short-term pullback before making investment decisions. 
